Skip to main content
OpenTrials

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,952 public trials 630 recruiting studies
Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Active, Not Recruiting

A Study of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022)

NCT05239728

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Mayo Clinic in Arizona - Phoenix ( Site 3554) Phoenix, Arizona, United States
  • City of Hope Comprehensive Cancer Center ( Site 3567) Duarte, California, United States
  • Moores Cancer Center-Clinical Trials Office- Genitourinary ( Site 3516) La Jolla, California, United States
  • UCLA Hematology/Oncology - Westwood (Building 200 Suite 140)-Department of Urology/Institute of Uro ( Site 3520) Los Angeles, California, United States
View all 285 locations
View Trial Details
Active, Not Recruiting

A Study of Belzutifan (MK-6482) Versus Everolimus in Participants With Advanced Renal Cell Carcinoma (MK-6482-005)

NCT04195750

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
Locations
  • Faculty Office Towers 1132 ( Site 1538) Birmingham, Alabama, United States
  • University of California San Diego Moores Cancer Center ( Site 1546) La Jolla, California, United States
  • St. Joseph Heritage Healthcare Local Lab ( Site 1531) Santa Rosa, California, United States
  • University of Colorado Cancer Center ( Site 1540) Aurora, Colorado, United States
View all 172 locations
View Trial Details
Active, Not Recruiting

Testing Cabozantinib With or Without Atezolizumab in Patients With Advanced Papillary Kidney Cancer, PAPMET2 Trial

NCT05411081

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Cancer Center at Saint Joseph's Phoenix, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Kaiser Permanente-Anaheim Anaheim, California, United States
View all 199 locations
View Trial Details
Active, Not Recruiting

Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors

NCT02496208

Conditions
Adenocarcinoma, Bladder Small Cell Neuroendocrine Carcinoma, Bladder Squamous Cell Carcinoma, +54 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
View Trial Details
Active, Not Recruiting

Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer

NCT04164082

Conditions
Bladder Flat Urothelial Carcinoma In Situ, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 391 locations
View Trial Details
Active, Not Recruiting

CISTO: Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer

NCT03933826

Conditions
Bladder Cancer, Cancer of the Bladder, Recurrent, Carcinoma, +19 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Cancer Center Phoenix, Arizona, United States
  • USC/Norris Comprehensive CA Center Los Angeles, California, United States
  • UCLA Los Angeles, California, United States
View all 36 locations
View Trial Details

Related conditions